to the investor
IN THE MEDIA
Cannabics Pharmaceuticals Raises $3,000,000 in Capital Raise Transaction
Cannabics Pharmaceuticals Announces Scientific Collaboration With A Leading CTC European Lab
Cannabics Pharmaceuticals Inc. Receives the Final Report of Its Research on Antitumor Properties of Cannabinoids Held in Israel.